You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股异动丨康宁杰瑞制药(9966.HK)逆势涨4.78% 多家大行唱多
格隆汇 09-09 15:20
格隆汇9月9日丨康宁杰瑞制药(9966.HK)今早见近半年低点后反弹,现逆势涨4.78%,报14.46港元,总市值135亿港元。摩根士丹利发表最新报告表示,康宁杰瑞生物制药股价在未来30天上升,发生此概率介乎70%至80%。考虑到公司产品线近期有多个催化剂,给予目标价20港元,评级“增持”。里昂此前发表报告指,集团治疗胆管癌新药KN035(Envafolimab)的临床进展令人鼓舞,料于今年第四季作生物制品上市申请(BLA),而治疗非小细胞肺癌的另一新药KN046亦进入三期临床,目标价由17.39港元升至21港元,评级维持买入。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account